These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1149779)

  • 1. Lack of effect of cholestyramine on the pharmacokinetics of clofibrate in man.
    Sedaghat A; Ahrens EH
    Eur J Clin Invest; 1975 Apr; 5(2):177-85. PubMed ID: 1149779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic study and bioavailability of three marketed compounds releasing p-chlorophenoxyisobutyric acid (CPIB) in volunteers.
    Harvengt C; Desager JP
    Int J Clin Pharmacol Biopharm; 1976 Sep; 14(2):113-8. PubMed ID: 1002348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clofibrate and clofibric acid: comparison of the metabolic disposition in rats and dogs.
    Cayen MN; Ferdinandi ES; Greselin E; Robinson WT; Dvornik D
    J Pharmacol Exp Ther; 1977 Jan; 200(1):33-43. PubMed ID: 833760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of clofibrate in familial hypercholesterolemia.
    Pichardo R; Boulet L; Davignon J
    Atherosclerosis; 1977 Apr; 26(4):573-82. PubMed ID: 193524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of clofibrate in patients with renal insufficiency.
    Viikari J; Anttila M; Kasanen A
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):77-80. PubMed ID: 6840929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the metabolism of clofibride, a hypolipaemic drug.
    Loiseau GP; Millischer RJ; Lohier PY; Mardiguian JS; Gilede AM; Ginocchio AV
    J Pharm Pharmacol; 1980 Jul; 32(7):483-8. PubMed ID: 6105184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clofibrate kinetics after single and multiple doses.
    Gugler R; Hartlapp J
    Clin Pharmacol Ther; 1978 Oct; 24(4):432-8. PubMed ID: 688733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clofibrate pharmacokinetics: effect of elevation of plasma-free fatty acids.
    Crouthamel WG; Cenedella RJ
    Pharmacology; 1975; 13(5):465-73. PubMed ID: 1208648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of food on the absorption of the p-chlorophenolic ester of chlorophenoxyisobutyric acid in man.
    Houin G; Shastri RA; Barre J; Pinchon B; Tillement JP
    Br J Clin Pharmacol; 1984 Mar; 17(3):341-5. PubMed ID: 6712867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A quantitative gaschromatographic method for the determination of p-chlorophenoxyisobutyric acid (clofibrinic acid) in human plasma (author's transl)].
    Häselbarth V
    Arzneimittelforschung; 1976; 26(11):2076-80. PubMed ID: 1037251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the mechanism of lowering of the cholesterol level by ethyl-alpha-p-chlorophenoxy-isobutyrate (clofibrate) (author's transl)].
    Nakamura H
    Hokkaido Igaku Zasshi; 1976 Jul; 51(4):289-97. PubMed ID: 1033897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state kinetics of bezafibrate and clofibrate in healthy female volunteers.
    Abshagen U; Spörl-Radun S; Marinow J
    Eur J Clin Pharmacol; 1980 Apr; 17(4):305-8. PubMed ID: 6995131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol absorption in man: effect of administration of clofibrate and/or cholestyramine.
    McNamara DJ; Davidson NO; Samuel P; Ahrens EH
    J Lipid Res; 1980 Nov; 21(8):1058-64. PubMed ID: 7462801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restraint of cholesterol accumulation in tissue pools associated with drastic short-term lowering of serum cholesterol levels by clofibrate or cholestyramine in hypercholesterolemic swine.
    Kim DN; Lee KT; Reiner JM; Thomas WA
    J Lipid Res; 1974 Jul; 15(4):326-31. PubMed ID: 4854142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of clofibrate in the rat. Acute and chronic administration.
    Baldwin JR; Witiak DT; Feller DR
    Biochem Pharmacol; 1980 Dec; 29(23):3143-54. PubMed ID: 7447955
    [No Abstract]   [Full Text] [Related]  

  • 16. Separation of two conjugates of clofibric acid (CPIB) found in the urine of subjects taking clofibrate.
    Faed EM; McQueen EG
    Clin Exp Pharmacol Physiol; 1978; 5(2):195-8. PubMed ID: 648038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of clofibric acid (CPIB) metabolites in plasma of patients on clofibrate therapy.
    Faed EM; McQueen EG
    Clin Exp Pharmacol Physiol; 1979; 6(3):267-73. PubMed ID: 466868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of clofibrate, cholestyramine, zanchol, probucol, and AOMA feeding on hepatic and intestinal cholesterol metabolism and on biliary lipid secretion in the rat.
    Turley SD; Dietschy JM
    J Cardiovasc Pharmacol; 1980; 2(3):281-97. PubMed ID: 6156326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent pharmacokinetics of clofibric acid in the non-human primate.
    Walmsley LM
    Arch Toxicol Suppl; 1984; 7():272-7. PubMed ID: 6595991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biliary lipid composition during treatment with different hypolipidaemic drugs.
    Angelin B; Einarsson K; Leijd B
    Eur J Clin Invest; 1979 Jun; 9(3):185-90. PubMed ID: 113218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.